EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Neuroprotective, neurogenic, and anticholinergic evidence of Ganoderma lucidum cognitive effects: Crucial knowledge is still lacking

Diandra A Luz, Alana M Pinheiro, Enéas A Fontes-Júnior, Cristiane S F Maia iD

Medicinal Research Reviews · 2023

DOI: 10.1002/med.21957 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, 2023. Verfasst von Diandra A Luz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pharmacology of Inflammation and Behavior, Institute of Health Science, Faculty of Pharmacy, Federal University of Pará, Belém, Pará, B…. Hauptthemen laut MEDLINE: Reishi, Triterpenes. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 91 Literaturangaben. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ganoderma lucidum is a mushroom that has been widely used for centuries in Asian countries for its antiaging properties. It is popularly known as “Ling Zhi,” “Reishi,” and “Youngzhi,” and because of its benefits, it is known as the “immortality mushroom.” Pharmacological assays have revealed that G. lucidum ameliorates cognitive impairments through inhibition of β‐amyloid and neurofibrillary tangle formation, antioxidant effect, reduction of inflammatory cytokine release and apoptosis, genic expression modulation, among other activities. Chemical investigations on G. lucidum have revealed the presence of metabolites such as triterpenes, which are the most explored in this field, as well as flavonoids, steroids, benzofurans, and alkaloids; in the literature, these have also been reported to have mnemonic activity. These properties of the mushroom make it a potential source of new drugs to prevent or reverse memory disorders, as actual medications are able to only alleviate some symptoms but are unable to stop the progress of cognitive impairments, with no impact on social, familiar, and personal relevance. In this review, we discuss the cognitive findings of G. lucidum reported in the literature, converging the proposed mechanisms through the several pathways that underlie memory and cognition processes. In addition, we highlight the gaps that deserve particular attention to support future studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ReishiTriterpenesHumansCholinergic AntagonistsAntioxidantsCognition

Stichwörter der Autor:innen

Ganoderma lucidumbioactive compoundcognitiondementiatriterpenes

Substanzen

Cholinergic AntagonistsAntioxidantsTriterpenes

Autor:innen und Institutionen

  • Laboratory of Pharmacology of Inflammation and Behavior, Institute of Health Science, Faculty of Pharmacy, Federal University of Pará, Belém, Pará, Brazil.

ORCID-Profile: Cristiane S F Maia

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Luz, D. A., Pinheiro, A. M., Fontes-Júnior, E. A., & Maia, C. S. F. (2023). Neuroprotective, neurogenic, and anticholinergic evidence of Ganoderma lucidum cognitive effects: Crucial knowledge is still lacking. Medicinal Research Reviews. https://doi.org/10.1002/med.21957

Vancouver

Luz DA, Pinheiro AM, Fontes-Júnior EA, Maia CSF. Neuroprotective, neurogenic, and anticholinergic evidence of Ganoderma lucidum cognitive effects: Crucial knowledge is still lacking. Medicinal Research Reviews. 2023. doi:10.1002/med.21957

BibTeX
@article{Luz2023,
  author = {Luz, Diandra A and Pinheiro, Alana M and Fontes-Júnior, Enéas A and Maia, Cristiane S F},
  title = {Neuroprotective, neurogenic, and anticholinergic evidence of Ganoderma lucidum cognitive effects: Crucial knowledge is still lacking},
  journal = {Medicinal Research Reviews},
  year = {2023},
  doi = {10.1002/med.21957}
}
Kostenlos starten →